The Beauty Health (SKIN): Growth-Adjusted P/E Ratio
The Beauty Health generates revenue through the supply of HydraFacial systems, combining hardware sales with the recurring sale of high-margin consumables. The P/E growth multiplier trend reflects asset value dynamics relative to earnings, with the indicator fixed at 0.00. While the Syndeo update and share buybacks provide growth potential, declining consumer spending on spa services are forcing the company to lower prices.
Analytical breakdowns for The Beauty Health (SKIN)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio The Beauty Health|SKIN - Long-Term Debt to Capital|Current Liabilities to Capital Beauty Health|SKIN - Company Total Debt|Debt to Net Assets Ratio The Beauty Health Company|SKIN - Company Long-Term Debts|Company Short-Term Debt BeautyHealth|Immediate Liquidity beautyhealth.com
- earnings and market ratios statistics:
SKIN - Net Profit|Projected Future Earnings The Beauty Health|SKIN - Price to Earnings Ratio|Forward P/E Multiple Beauty Health|SKIN - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio The Beauty Health Company|SKIN - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months BeautyHealth|SKIN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months beautyhealth.com|SKIN - Earnings growth in current year|Expected earnings per share trend next year The Beauty Health
- sales revenue and business income indicators:
Summary company analytics:Beauty Health, SKIN
The Beauty Health (SKIN) maintains steady expansion driven by the closed B2B model of HydraFacial, which mandates the use of proprietary consumables, a trend reflected in the PEG ratio dynamics. This metric compares the P/E ratio to earnings growth rates, where values below one signal that the asset is undervalued relative to its expansion, turning this chart into a tool for identifying high-yield "rockets" with confirmed growth potential.
Competing companies
HCA Holdings - Growth-Adjusted P/E Ratio|Tenet - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio FMS (Fresenius Medical Care)|SOLV: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Encompass Health Corp|Universal Health Services (UHS) - Price/Earnings to Growth Ratio|DaVita Inc. (DVA) - PEG Multiple|RDNT (RadNet Management) - PEG Multiple|Option Care Health, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Ratio Surgery Partners (SGRY)|PINC - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio nationalvision.com EYE|Price to Net Income Growth Ratio Progyny, Inc.|ARDT - Price/Earnings to Growth Ratio|Select Medical Holdings - Company Value to Earnings Growth Ratio|Apollo Medical Holdings (ASTH) - Price/Earnings to Growth Ratio|MD - Growth-Adjusted Market Cap to Net Income|USPH (usph.com) - PEG Multiple|Growth-Adjusted P/E Ratio PNTG (The Pennant Group Corp)|PEG Multiple ORGO|NUTX - Price to Earnings Adjusted for Growth Rate|aunainvestors.com - Price/Earnings to Growth Multiple|PEG Multiple SBC Medical Group Holdings Inc. SBC|Evolus Corp - PEG Multiple|Growth-Adjusted Payback Ratio CYH (Community Health Systems Inc)|MediWound Ltd (MDWD) - Price/Earnings to Growth Ratio|BTMD - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio The Joint|Price/Earnings to Growth Multiple DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Growth-Adjusted Payback Ratio|PEG Multiple Gain Therapeutics (GANX)|PEG Multiple EUDA (EUDA Health)|Growth-Adjusted Payback Ratio BMGL|CollPlant Ltd - PEG Multiple|Price to Net Income Growth Ratio Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Price/Earnings to Growth Ratio|ASHS - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio MEDIROM Healthcare Group|PEG Multiple avalon-globocare.com|PEG Multiple DHAI|XAGE (Carmell Therapeutics Corporation) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio NewGenIvf Corp NIVF|ATIP (atipt.com) - Market Cap to Earnings and Growth Ratio|CareMax, Inc - PEG Multiple|Growth-Adjusted Payback Ratio KDLY (Kindly MD, Inc.)|MODV: PEG Multiple|Growth-Adjusted P/E Ratio NVOS|Price/Earnings to Growth Ratio SunLink Health Systems, Inc.|PEG Multiple IMAC Holdings, Inc.
